CLINICAL_TRIALS
trial_result
· 2010-01-22
Clinical Trial Update: Tiotropium / Respimat One Year Study in COPD. [Phase 3]
Summary
A Phase 3 one-year trial update assessing tiotropium delivered by Respimat in chronic obstructive pulmonary disease, with the study completed and results posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2010-01-22